DICLOSAL

This brand name is authorized in Nigeria. It is also authorized in Romania.

Active ingredients

The drug DICLOSAL contains one active pharmaceutical ingredient (API):

1	Diclofenac UNII QTG126297Q - DICLOFENAC SODIUM
	Diclofenac is a non-steroidal anti-inflammatory drug. The mechanism of action of diclofenac in AK may be related to the inhibition of the cycloxygenase pathway leading to reduced prostaglandin E2 (PGE2) synthesis. In addition, immunohistochemistry (IHC) from skin biopsies ac revealed that the clinical effects of diclofenac in AK are primarily due to anti-inflammatory, anti-angiogenic and possibly anti-proliferative effects and apoptosis-inducing mechanisms.
	Read more about Diclofenac

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A11-100617	Tablet	Diclosal Tablets 50 mg TAB 50 mg 1 X 10 Tablets	55 NF-PP-322292 Diclosal Tablets 50 mg Diclofenac Tablets BP 50 mg Each film-coated tablet contains Diclofenac sodium BP 50 mg Maize Starch BP 110.89 mg Dibasic Calcium Phosphate BP 90 mg Povidone BP (K-30) BP 2.50 mg Microcrystalline cellulose BP 65 mg Purified water BP 0.0324 mg Methyl Paraben BP 0.10 mg Propyl Paraben BP 0.01 mg Purified Talc BP 4 mg Magnesium Stearate BP 2 mg Sodium Starch Glycolate BP 5 mg HPMC BP 7.50 mg Colloidal Anhydrous Silica BP 0.50 mg Erythrosine IH 0.50 mg PEG-6000 BP 0.30 mg Isopropyl Alcohol BP 0.0575ml Met A11-100617 Drugs Nigerian Products 110tabs POM 1 3/22/2023 SAGAR VITACEUTICALS NIGERIA LTD., PLOT 2, LADIPO OLUWOLE STREET 9022977711 suptpharm@svnl.in Sagar Vitaceuticals Nigeria Limited, Plot 2, Ladipo Oluwole Street, Off Oba Akran Avenue, Ikeja, Lagos, Nigeria, Nigeria	21/12/2023
A11-100621	Tablet	DICLOSAL Tablets 100 mg TAB 100 mg 1 X 10	56 NF-PP-334207 DICLOSAL Tablets 100 mg Diclofenac sodium Tablets BP 100 mg Each film-coated tablet contains Diclofenac sodium BP 100 mg Maize Starch BP 60.89 mg Diabasic Calcium Phosphate BP 90mg Povidone (K-30) BP 2.50mg Microcrystalline cellulose BP 65 mg Purified water BP 0.0324 mg Methyl Paraben BP 0.10 mg Propyl Paraben BP 0.01mg Purified Talc BP 4 mg Magnesium Stearate BP 2 mg Sodium Starch Glycolate BP 5mg HPMC BP 7.50mg Colloidal Anhydrous Silica BP 0.50mg Erythrosine BP 0.50mg PEG-6000 BP 0.30mg Isopropyl Alcohol 0.0575ml Methylene chlori A11-100621 Drugs Nigerian Products 110tabs POM 1 5/23/2023 SAGAR VITACEUTICALS NIGERIA LTD., PLOT 2, LADIPO OLUWOLE STREET 9022977711 suptpharm@svnl.in Sagar Vitaceuticals Nigeria Limited, Plot 2, Ladipo Oluwole Street, Off Oba Akran Avenue, Ikeja, Lagos, Nigeria, Nigeria	21/12/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
M02AA15	Diclofenac	M Musculo-skeletal system → M02 Topical products for joint and muscular pain → M02A Topical products for joint and muscular pain → M02AA Antiinflammatory preparations, non-steroids for topical use
Discover more medicines within M02AA15

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A11-100617, A11-100621
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W55340001, W55340002, W55341001, W55341002, W57197001, W57197002